Concurrent nonavalent human papillomavirus (HPV) vaccination and immune stimulation with imiquimod to treat recalcitrant HPV-associated high grade vaginal intra-epithelial neoplasia
This is the first report describing detailed T cell responses to viral-like proteins contained in an HPV specific vaccine given in combination with Imiquimod for treatment of persistent VAIN2/3. We postulate that stimulation of the innate immune system with Imiquimod and the specific CD4 and CD8T ce...
Main Authors: | R. Farrell, J. Zaunders, IM. Poynten, L. Anderson, L. Evans |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Gynecologic Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578924000298 |
Similar Items
-
HPV vaccine in the treatment of usual type vulval and vaginal intraepithelial neoplasia: a systematic review
by: Stacey Bryan, et al.
Published: (2019-01-01) -
Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia
by: Cheng-Tao Lin, et al.
Published: (2012-12-01) -
Cytology and HPV Co-Testing for Detection of Vaginal Intraepithelial Neoplasia: A Retrospective Study
by: Frederik A. Stuebs, et al.
Published: (2023-09-01) -
Application of 2011 International Federation for Cervical Pathology and Colposcopy Terminology on the Detection of Vaginal Intraepithelial Neoplasia
by: Zhou Q, et al.
Published: (2020-07-01) -
Human Papillomavirus Infections in Cervical Samples From HIV-Positive Women: Evaluation of the Presence of the Nonavalent HPV Genotypes and Genetic Diversity
by: Catia Sias, et al.
Published: (2020-11-01)